ClinTec ceo receives Honorary Doctorate

For her contribution to life sciences industry

Dr Rabinder Buttar has been awarded a Doctorate of the University (DUniv) by the University of the West of Scotland.

This honorary doctorate was awarded in recognition of Dr Buttar’s contribution to the life sciences Industry over 20 years and for the foundation and development of ClinTec International.

Professor Seamus McDaid, principal and vice chancellor of the University of the West of Scotland, said: ‘We are delighted to award Dr Buttar with an Honorary Doctorate. As chief executive of ClinTec International, she is one of the country’s most important business leaders, making a hugely important contribution to the Scottish economy.’

At the graduation ceremony, which took place in Paisley, Dr Buttar said: ‘The University has created an exceptional pool of local and international graduates and I am honoured to come back here after 20 years and accept this degree. These graduates here today have successfully completed one chapter of their lives and as they open the next one their learning should never stop.

‘In the current challenging times, graduates should seek local as well as global opportunities, look to do something they feel passionate about, be even more determined than ever before to succeed and then further success will be in their hands. The University and its excellent staff have prepared them well for the challenges that lie ahead.

‘I feel honoured and privileged to join the Court and Senate today in recognising and celebrating in some of Scotland’s academic achievements.’

Dr Buttar has also been named as the Ernst & Young Entrepreneur of the Year for Scotland and the Institute of Directors’ Regional Director of the Year for the West of Scotland.

You may also like

Research & Development

ClinTec expands into China, Singapore and Thailand

Increases presence in emerging markets
Finance

Pharmaceutical firms win Queen’s Awards for Enterprise

Eight firms are lauded for their success in innovation and international trade
Manufacturing

Andelyn Biosciences launches LVV Curator platform, bringing proven viral vector platform pedigree to Lentiviral Vector manufacturing for cell therapies

New platform leverages the established Curator platform methodology to industrialise Lentivirus processes from concept to clinic
Manufacturing

Bora Group to acquire MacroGenics’ manufacturing operations and CDMO business

The purchase will hand the Group a biologics drug substance manufacturing facility and a warehousing centre in Maryland, which Bora plans to use in cooperation with Tanvex Biopharma to scale its end-to-end biologics platform
Finance

Cambridge biotech Verinnogen secures £500k CPI investment to advance cancer drug development

The investment will advance a handheld device delivering more precise and reproducible tumour size measurements in preclinical oncology research, addressing variability in existing techniques that can slow drug development and necessitate costly repeat studies
Manufacturing

Adragos Pharma appoints Kostas Rengis as Chief Executive Officer

Munich, Germany – May 7th, 2026 – Adragos Pharma, a global contract development and manufacturing organisation (CDMO), today announced the appointment of Konstantinos (Kostas) Rengis as its new Chief Executive officer, succeeding Dr. Andreas Raabe, who founded the company and has led it over the past six years
Research & Development

Syngene strengthens leadership team with two key appointments to support next phase of growth

Abhijit Zutshi joins as CCO and Maninder Kapoor Puri as CHRO. India/U.S./UK, 1 May 2026: Syngene International, a global contract research, development, and manufacturing organization (CRDMO), today announced the Abhijit Zutshi as Chief Commercial Officer (CCO) and Maninder Kapoor Puri as Chief Human Resources Officer (CHRO), effective 1 May 2026
Subscribe now